# Importer of Controlled Substances Application: Globyz Pharma, LLC; Correction
> **Notice** · Notice of application; correction. · Published 2022-01-24 · 87 FR 3587
## Document
- **Document number:** 2022-00852
- **Category:** application
- **Type:** Notice
- **Action:** Notice of application; correction.
- **Citation:** 87 FR 3587
- **Publication date:** 2022-01-24
- **Party named:** Globyz Pharma, LLC; Correction
## Abstract

The Drug Enforcement Administration (DEA) published a document in the Federal Register on August 12, 2021, concerning a notice of application. The document indicated the approved drug code (1205-- Lisdexamfetamine) as a schedule I. The correct drug schedule should read schedule II.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2022/01/24/2022-00852/importer-of-controlled-substances-application-globyz-pharma-llc-correction)
---
*AI Analytics · CC0 1.0*